Institutional Research Information Service
UCL Logo
Please report any queries concerning the funding data grouped in the sections named "Externally Awarded" or "Internally Disbursed" (shown on the profile page) to your Research Finance Administrator. Your can find your Research Finance Administrator at http://www.ucl.ac.uk/finance/research/post_award/post_award_contacts.php by entering your department
Please report any queries concerning the student data shown on the profile page to:

Email: portico-services@ucl.ac.uk

Help Desk: http://www.ucl.ac.uk/ras/portico/helpdesk
Epilepsy is a devastating condition affecting over 50 million people worldwide. Patients with epilepsy suffer from reoccurring unprovoked seizures. The goal of current treatment practice is to enable patients to live unrestricted lives by controlling the seizures with anti-epileptic drugs – Epilepsy cannot be cured to date. EPITARGET is a EU funded consortium focused on addressing this area of medical need. The central premise and vision is that by using a combinatorial approach to identify appropriate biomarkers that allow the prediction of the disease and by developing effective undefinedanti-epileptogenic therapeutics, patients at risk can be treated before they even have epilepsy. Our role in the project is to explore ways in which novel therapies could be delivered to the brain by overcoming or bypassing the BBB. We utilise supramolecular assemblies of engineered polymers to facilitate transport into the brain.
1 Researchers
 More search options
Status: Active
Topic-related Countries
University College London - Gower Street - London - WC1E 6BT Tel:+44 (0)20 7679 2000

© UCL 1999–2011

Search by